OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging
Brian Effer, Isabela Perez, Daniel Ulloa, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2086-2086
Open Access | Times Cited: 11
Brian Effer, Isabela Perez, Daniel Ulloa, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2086-2086
Open Access | Times Cited: 11
Showing 11 citing articles:
A Virus-Inspired RNA Mimicry Approach for Effective Cancer Immunotherapy
In-Suk Jang, Kyuha Yum, Sang Woo Han, et al.
Journal of Materials Chemistry B (2025)
Closed Access
In-Suk Jang, Kyuha Yum, Sang Woo Han, et al.
Journal of Materials Chemistry B (2025)
Closed Access
The role of monoclonal antibodies in the treatment of pancreatic and colon cancers
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable (scFv) Antibody Selection against Claudin 18.2 via Phage Display
Brian Effer, Daniel Ulloa, Camila Dappolonnio, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 2
Brian Effer, Daniel Ulloa, Camila Dappolonnio, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 2
Navigating the Future: Advancements in Monoclonal Antibody Nanoparticle Therapy for Cancer
Harshad S. Kapare, Mayuri Bhosale, Ritesh P. Bhole
Journal of Drug Delivery Science and Technology (2024) Vol. 104, pp. 106495-106495
Closed Access | Times Cited: 1
Harshad S. Kapare, Mayuri Bhosale, Ritesh P. Bhole
Journal of Drug Delivery Science and Technology (2024) Vol. 104, pp. 106495-106495
Closed Access | Times Cited: 1
Nectin-4 has emerged as a compelling target for breast cancer
Hui Wang, Dejuan Sun, Jinxia Chen, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176129-176129
Closed Access | Times Cited: 3
Hui Wang, Dejuan Sun, Jinxia Chen, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176129-176129
Closed Access | Times Cited: 3
Emicizumab as a Promising Form of Therapy for Type A Hemophilia - A Review of Current Knowledge from Clinical Trials
Katarzyna Grabowska, Michalina Grzelak, Lin-Yong Zhao, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 9, pp. 719-737
Closed Access
Katarzyna Grabowska, Michalina Grzelak, Lin-Yong Zhao, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 9, pp. 719-737
Closed Access
Monoclonal Antibody based Therapy against Cancer
R. C. Agrawal, Srishti Shankar
Eastern Journal of Medical Sciences (2024) Vol. 9, Iss. 2
Open Access
R. C. Agrawal, Srishti Shankar
Eastern Journal of Medical Sciences (2024) Vol. 9, Iss. 2
Open Access
Treatment patterns and factors associated with discontinuation of monoclonal antibodies
Muzoon Matar Saleh Alkaabi, Syed Arman Rabbani, Padma Gm Rao, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access
Muzoon Matar Saleh Alkaabi, Syed Arman Rabbani, Padma Gm Rao, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access
Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery
Bayan Alkhawaja, Duaa Abuarqoub, Mohammad Ahmad Al-Natour, et al.
Bioconjugate Chemistry (2024)
Open Access
Bayan Alkhawaja, Duaa Abuarqoub, Mohammad Ahmad Al-Natour, et al.
Bioconjugate Chemistry (2024)
Open Access
Nectin-4: A promising prognostic marker and therapeutic target in cancer
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, et al.
International review of cell and molecular biology (2024), pp. 223-255
Closed Access
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, et al.
International review of cell and molecular biology (2024), pp. 223-255
Closed Access
Evaluation of orphan maintained biological medicinal products in the European Union between 2018 to 2023: a regulatory perspective
Paolo Caferra, T. Fraisse, Maria Letizia Trincavelli, et al.
Expert Opinion on Biological Therapy (2024)
Closed Access
Paolo Caferra, T. Fraisse, Maria Letizia Trincavelli, et al.
Expert Opinion on Biological Therapy (2024)
Closed Access
